Complete Genomics to Design New Generation of Sequencers; Reports Backlog of 2,100 Genomes

Complete Genomics officials also disclosed that a court has dismissed two out of three patents in the company's ongoing patent-infringement suit with Illumina.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.